Chester County News and Community Website
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has received a U.S. patent covering the use of its drug candidate buntanetap to prevent and treat neurological injuries linked to brain …
Annovis Secures U.S. Patent for Buntanetap Neurological Use Read More
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said the European Patent Office has granted a patent covering its lead product candidate QTORIN 3.9% rapamycin gel, extending intellectual property protection …
European Patent Office Grants Palvella Patent for QTORIN Rapamycin Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (OTCID: WINT) has strengthened its intellectual property position with newly allowed and granted patents in Canada, Mexico, and Israel, reinforcing the company’s long-term strategy …
Windtree Expands Global Patent Portfolio as Heart Failure Pipeline Gains Momentum Read More
WYNNEWOOD, PA — A researcher with Main Line Health has secured a U.S. patent for protein fragments that could be used to both detect and prevent Lyme disease, offering hope …
Main Line Health Researcher Patents New Tools To Detect and Prevent Lyme Disease Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced this week that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new patent …
Madrigal Pharmaceuticals Secures Key Patent for Rezdiffra, Extending Market Protection to 2044 Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous treatment …
Windtree Therapeutics Secures U.S. Patent for Istaroxime Heart Failure Treatment Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the issuance of U.S. patent No. 12,329,748 by the United States Patent and Trademark Office (USPTO), providing increased protection for its …
Palvella Therapeutics Secures New Patent for QTORIN™ Rapamycin Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced significant advancements in the intellectual property backing its AVIM (Atrioventricular Interval Modulation) therapy pipeline. Over the past year, …
Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation Read More
MALVERN, PA — Rajant Health Incorporated (RHI) has been granted a new patent for its innovative Parallel Adaptive Motion Artifact Removal technology, marking a major advancement in wearable health monitoring …
Rajant Health Secures Patent for Cutting-Edge Wearable Monitoring Technology Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has secured its fifth U.S. patent for QTORIN™ 3.9% rapamycin anhydrous gel, reinforcing its position in the development of treatments for rare …
Palvella Therapeutics Secures New U.S. Patent for QTORIN Rapamycin Read More